Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches.

Das L, Das M, Barkalita LM, Borah P, Chetia A, Baro MR, Chakraborty R, Dutta A

Open source

DOI
10.1007/s10787-026-02407-y
Published
2026 Sep 25
Container
Inflammopharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10787-026-02407-y,
  title = {Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches.},
  author = {Das L and Das M and Barkalita LM and Borah P and Chetia A and Baro MR and Chakraborty R and Dutta A},
  year = {2026},
  journal = {Inflammopharmacology},
  doi = {10.1007/s10787-026-02407-y},
  url = {https://doi.org/10.1007/s10787-026-02407-y}
}

RIS

TY  - JOUR
TI  - Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches.
AU  - Das L
AU  - Das M
AU  - Barkalita LM
AU  - Borah P
AU  - Chetia A
AU  - Baro MR
AU  - Chakraborty R
AU  - Dutta A
PY  - 2026
JO  - Inflammopharmacology
DO  - 10.1007/s10787-026-02407-y
UR  - https://doi.org/10.1007/s10787-026-02407-y
ER  - 

APA

L, D., M, D., LM, B., P, B., A, C., MR, B., R, C., & A, D. (2026). Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches.. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02407-y

Source records